CAR T cell therapy may eliminate tumor cells missed by surgery

The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells.

From Penn Medicine News

Advances in cancer research

Recent research shows promise in a novel CAR T therapy after cancer relapse, and a novel treatment for multiple myeloma.

From Penn Medicine News

CAR T cell therapy reaches beyond cancer

Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies.

From Penn Medicine News

Monkeypox: What is known and unknown

The current outbreak of monkeypox is showing no sign of slowing. Stuart Isaacs of the Perelman School of Medicine, an expert on poxviruses, sheds light on the disease, its prevention and treatment, and what to watch for this fall.

Katherine Unger Baillie

In the News


The race to supercharge cancer-fighting T cells

Carl June and Avery Posey of the Perelman School of Medicine discuss the progression and expansion of CAR-T cell therapies.


MIT Technology Review

What’s next for mRNA vaccines

Norbert Pardi of the Perelman School of Medicine and colleagues are developing a universal mRNA flu vaccine, featuring remarks from mRNA pioneer Katalin Karikó.



Researchers make important progress toward a possible universal flu vaccine

Scott Hensley of the Perelman School of Medicine and colleagues are using mRNA technology to develop a universal flu vaccine.



Health experts are split on who should get COVID booster shots and when

Stanley Plotkin and Paul Offit of the Perelman School of Medicine share their thoughts on COVID vaccine efficacy and their desire for more concrete booster data.


Jerusalem Post

TAU establishes center for autoimmune research

The Penn Colton Center for Autoimmunity at the Perelman School of Medicine is noted for its experimental and theoretical studies in immunology.



CRISPR gene-editing may boost cancer immunotherapy, new study finds

Carl June of the Perelman School of Medicine says that off-the-shelf CAR-T cell therapies using CRISPR would be a game-changer.